source
- FDA issues rule to allow non-animal testing methods for drug safetyFDA issued a direct final rule that updates its regulations to clarify that non-animal methods may be used for safety testing of drugs and biological products before they are tested in humans. The…
- Beacon Therapeutics reports successful gene-therapy trial for rare X-linked retinitis pigmentosaBeacon Therapeutics announced that its gene-therapy candidate for X-linked retinitis pigmentosa (XLRP) achieved its primary endpoint in a pivotal trial. The result marks a breakthrough for the rar…